143 results
Page 6 of 8
425
otqq4fx
5 May 21
Business combination disclosure
5:24pm
6-K
uit3bfjsil90b3qte9n
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.5
9mappeyx2omc eu
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
syo9 mcrhtgwa
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
842 iel4v02svr5x5
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
6-K
EX-99.1
8zdk7iv7
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
EX-2.7
vx2a5 a1btas
30 Apr 21
Annual report (foreign)
12:53pm
20-F
rv95mok9x9f4e6r
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.3
56q esl250abzp
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.2
nz9wedl dnzp
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.5
0ddy2d
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.4
aen0v
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.6
tejr9t obl
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.1
falzjrhl8kie8fbrh
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
424B3
bg9 1e6mtqmdw
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
4yaro
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
6-K
EX-99.1
e3yv eg733b3767910
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B4
y0p3omz
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
0rj5r49
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
szdl 2ct48
8 Jan 21
Registration statement (foreign)
4:58pm